When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. Keeping that in mind, here is one stock poised to prove Wall Street wrong and two facing legitimate challenges.

Consensus Price Target: $119.21 (9.3% implied return)

Originally founded as a Wisconsin paper mill in 1872, Kimberly-Clark (NYSE:KMB) is now a household products powerhouse known for personal care and tissue products.

Why Do We Think Twice About KMB?

Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy

Projected sales growth of 2.1% for the next 12 months suggests sluggish demand

Capital intensity has ramped up over the last year as its free cash flow margin decreased by 5 percentage points

At $109.05 per share, Kimberly-Clark trades at 14.3x forward P/E. To fully understand why you should be careful with KMB, check out our full research report (it’s free).

Consensus Price Target: $14.11 (-11% implied return)

Created through the 2020 merger of Mylan and Pfizer's Upjohn division, Viatris (NASDAQ:VTRS) is a healthcare company that develops, manufactures, and distributes branded and generic medicines across more than 165 countries worldwide.

Why Do We Think VTRS Will Underperform?

Annual sales declines of 4.4% for the past two years show its products and services struggled to connect with the market during this cycle

Earnings per share fell by 13.2% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable

Negative returns on capital show management lost money while trying to expand the business, and its shrinking returns suggest its past profit sources are losing steam

Viatris’s stock price of $15.85 implies a valuation ratio of 6.6x forward P/E. Read our free research report to see why you should think twice about including VTRS in your portfolio, it’s free.

Consensus Price Target: $321 (12.8% implied return)

Founded in 1970 by a Motorola employee, Western Digital (NASDAQ: WDC) is a leading producer of hard disk drives, SSDs and flash memory.

Why Are We Fans of WDC?

Market share is on track to rise over the next 12 months as its 31.8% projected revenue growth implies demand will accelerate from its two-year trend

Operating margin improved by 16.1 percentage points over the last five years as it eliminated redundant costs

Free cash flow margin grew by 14.7 percentage points over the last five years, giving the company more chips to play with

Western Digital is trading at $284.70 per share, or 25.2x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.